| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 149861-22-3 | 6-Amino-3-ethylphenol hydrochloride | C8H11NO.HCl |
| 149877-41-8 | Bifenazate | C17H20N2O3 |
| 149881-40-3 | Trandolapril Impurity D | C24H32N2O4 |
| 149888-94-8 | Azimilide dihydrochloride | C23H28ClN5O3.2(HCl) |
| 149890-38-0 | 4-Cyanophenyl 4'-trans-ethylcyclohexylcarboxylate | C16H18NO2 |
| 149904-87-0 | Darglitazone sodium | C23H20N2O4S.Na |
| 149908-53-2 | Azimilide | C23H28ClN5O3 |
| 149910-98-5 | 7-Bromo-3,4-dihydro-1H-2-benzopyran | C9H9BrO |
| 149917-88-4 | (R)-2-Diphenyphosphino-2'-hydroxyl-1,1'-binaphthyl | C32H23OP |
| 149920-56-9 | Idraparinux sodium | C38H55O49S7.9Na |
| 149923-10-4 | 4-Chlorobenzylzinc chloride | C7H6Cl2Zn |
| 149926-20-5 | Hetisine hydrochloride | C20H27NO3.HCl |
| 149926-91-0 | Revatropate | C19H27NO4S |
| 149934-20-3 | 9-Aminominocycline sulfate | C23H28N4O7.H2SO4 |
| 149934-21-4 | 9-Amino-minocycline hydrochloride | C23H28N4O7.HCl |
| 149947-15-9 | 3-Bromo-2-fluorobenzaldehyde | C7H4BrFO |
| 149947-16-0 | 1-Bromo-3-bromomethyl-2-fluorobenzene | C7H5Br2F |
| 149947-19-3 | 4-Bromo-2-fluorocinnamic acid | C9H6BrFO2 |
| 149949-30-4 | 2,6-Difluoro-3-methoxybenzaldehyde | C8H6F2O2 |
| 149965-40-2 | 5-Bromo-2-chlorobenzyl alcohol | C7H6BrClO |
| 149965-41-3 | 5-Bromo-2-chlorobenzyl bromide | C7H5Br2Cl |
| 149965-78-6 | Benzyl but-3-ynylcarbamate | C12H13NO2 |
| 149968-10-5 | 3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]-alpha-ethenylbenzenemethanol | C20H16ClNO |
| 149968-11-6 | Methyl (E)-2-[3-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-oxopropyl]benzoate | C28H22ClNO3 |
| 149968-28-5 | 2-butyl-4-chloro-1H-imidazole-5-carboxylic acid | C8H11ClN2O2 |
| 149968-36-5 | 1,3-Bis[(di-tert-butylphosphino)methyl]benzene | C24H44P2 |
| 149977-36-6 | 3-(2-Nitro-1-propenyl)thiophene | C7H7NO2S |
| 149978-57-4 | 5-Amino-1-(3-chloro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-2-yl)-1H-pyrazole-4-carbonitrile | C11H11ClN6 |
| 149989-64-0 | 5'-O-(4,4-Dimethoxytrityl)-2'-O-[(tert-butyl)dimethylsilyl]-N-[[4-(tert-butyl)phenoxy]acetyl]adenosine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite | C58H76N7O9PSi |
| 149989-66-2 | 5'-O-(4,4-Dimethoxytrityl)-2'-O-[(tert-butyl)dimethylsilyl]-N-[[4-(tert-butyl)phenoxy]acetyl]cytidine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite | C57H76N5O10PSi |
| 149989-68-4 | 5'-O-(4,4-Dimethoxytrityl)-2'-O-[(tert-butyl)dimethylsilyl]-N-[[4-(tert-butyl)phenoxy]acetyl]guanosine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite | C58H76N7O10PSi |
| 149989-79-7 | 2-Bromobenzylboronic acid pinacol ester | C13H18BBrO2 |
| 149998-38-9 | Gelomuloside A | C29H34O15 |
| 149998-39-0 | Gelomuloside B | C28H32O15 |
| 149998-51-6 | O-Acetylschisantherin L | C29H32O10 |
| 150008-24-5 | tert-Butyl 4-(hydroxyimino)piperidine-1-carboxylate | C10H18N2O3 |
| 150009-58-8 | N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-D-aspartic acid 4-(phenylmethyl) ester | C26H23NO6 |
| 150009-60-2 | N-[(1,1-Dimethylethoxy)carbonyl]-O-(phenylmethyl)-D-homoserine | C16H23NO5 |
| 150010-20-1 | 2-Bromo-5-methylpyrimidine | C5H5BrN2 |
| 150018-99-8 | 1-Benzyl-3-hydroxypiperidine-3-carbonitrile | C13H16N2O |
| 150026-72-5 | 2-[(3R)-3-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-hydroxypropyl]benzoic acid methyl ester | C28H24ClNO3 |
| 150026-73-6 | Montelukast Impurity 40 | C28H24ClNO2 |
| 150026-75-8 | [R-(E)]-alpha-[3-[2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-2-(1-hydroxy-1-methylethyl)benzenepropanol | C29H28ClNO2 |
| 150033-80-0 | 2-(4-(Methoxycarbonyl)benzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C15H21BO4 |
| 150033-85-5 | Cycloshizukaol A | C32H36O8 |
| 150044-24-9 | [23,24,25,26,27-13C5]Cholesterol | C27H46O |
| 150047-85-1 | (2S)-5-(Cyclohexyloxy)-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-5-oxopentanoic acid | C26H29NO6 |
| 150054-50-5 | 4-Chloro-3,5-dimethyl-2-pyridinemethanol | C8H10ClNO |
| 150058-27-8 | Methyl 2-ethoxybenzimidazole-7-carboxylate | C11H12N2O3 |
| 150058-29-0 | 2-Ethoxy-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-4-carboxylic acid methyl ester | C44H36N6O3 |